Differences in the Prevalence of Screen-Detected Depression After Acute Coronary Syndrome Between Health Systems in the USA: Findings from CODIACS-QoL Randomized Controlled Trial.
Differences in the Prevalence of Screen-Detected Depression After Acute Coronary Syndrome Between Health Systems in the USA: Findings from CODIACS-QoL Randomized Controlled Trial.
复制标题
美国卫生系统之间通过屏幕检测到的急性冠脉综合征后抑郁症患病率的差异:CODIACS-QoL 随机对照试验的结果。
DOI:
10.1007/s11606-021-07049-0
复制
发表时间:
2022
影响因子:
5.7
通讯作者:
Kronish,IanM
中科院分区:
文献类型:
--
作者:
Moise,Nathalie;Davidson,KarinaW;Clarke,GregoryN;Dolor,RowenaJ;Margolis,KarenL;Kronish,IanM
BACKGROUNDOne in 5 individuals has elevated depressive symptoms following acute coronary syndromes (ACS), increasing the risk of recurrent cardiovascular events and mortality. 1 Multiple advisories recommend depression screening and comprehensive treatment in post-ACS patients. 1 While depression rates vary by patient characteristics, little is known about differences in depression screen-positive rates at the health system level.OBJECTIVEWe sought to determine whether post-ACS depression detection rates differ by healthcare system after adjusting for patient characteristics.METHODSWe used baseline visit data from the CODIACS-QoL, a multi-health system 3-group randomized clinical trial of depression screening with and without enhanced depression care versus no depression screening. 2 We recruited post-ACS patients between November 2013 and April 2017 from 4 geographically diverse health systems: HealthPartners (Minneapolis, MN); Duke University Health System (Durham, NC); Kaiser Permanente Northwest (Portland, OR); and New York-Presbyterian Hospital/Columbia (New York, NY). We screened electronic health records for eligible English-or Spanish-speaking individuals≥ 21 years old and with documented ACS within 2–12 months of enrollment based on standardized International Classification of Diseases discharge codes for acute myocardial infarction and unstable angina. We excluded individuals with prior or current depression diagnosis or treatment; life expectancy< 1 year; prior or current history of bipolar disorder, suicidal risk, or psychosis; current substance abuse; dementia; current pregnancy; or severe chronic illness requiring frequent hospitalizations.